Related Experiment Video
Updated: Apr 11, 2026

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
In vitro activity of josamycin against Streptococcus pyogenes isolated from patients with upper respiratory tract
M Auzou1, J Caillon2, C Poyart3
1Service de microbiologie et CNR associé de la résistance aux antibiotiques, CHU de Caen, 14033 Caen, France.
Objectives:
The primary objective of our study was to obtain susceptibility data for josamycin against Streptococcus pyogenes isolated from patients presenting with upper respiratory tract infections in France. The secondary objective was to characterize the molecular mechanism of resistance in macrolide-resistant isolates.
Patients And Methods:
MICs of erythromycin, clarithromycin, azithromycin, josamycin, and clindamycin were determined by the broth microdilution method. Resistance genes erm(B), erm(TR), and mef(A) were screened by PCR.
Results:
The MIC50 and MIC90 of josamycin against 193 isolates of S. pyogenes were 0.12 and 0.25mg/L, respectively, with a resistance rate estimated at 4.7%. Resistance was due to the erm(B) gene whereas strains harboring erm(TR) or mef(A) remained susceptible.
Conclusions:
Josamycin was active against >95% of S. pyogenes isolated from patients with upper respiratory tract infections, and can be used as an alternative for the treatment of pharyngitis.
Insights
Josamycin demonstrates high activity against Streptococcus pyogenes, with over 95% susceptibility observed in isolates from upper respiratory tract infections. This macrolide antibiotic can serve as an alternative treatment for pharyngitis.
Area of Science:
- Microbiology
- Infectious Diseases
- Pharmacology
Background:
- Streptococcus pyogenes is a common cause of upper respiratory tract infections.
- Macrolide resistance in S. pyogenes is a growing concern.
- Josamycin is a macrolide antibiotic with potential therapeutic applications.
Purpose of the Study:
- To evaluate the in vitro activity of josamycin against clinical isolates of S. pyogenes.
- To determine the prevalence of macrolide resistance mechanisms in these isolates.
- To assess josamycin's potential as an alternative treatment for S. pyogenes infections.
Main Methods:
- Broth microdilution method was used to determine Minimum Inhibitory Concentrations (MICs) for josamycin and other antibiotics.
- Polymerase Chain Reaction (PCR) was employed to screen for key macrolide resistance genes (erm(B), erm(TR), mef(A)).
- Susceptibility testing was performed on 193 S. pyogenes isolates from French patients.
Main Results:
- Josamycin exhibited potent activity with MIC50 and MIC90 values of 0.12 and 0.25 mg/L, respectively.
- The overall resistance rate to josamycin was low, estimated at 4.7%.
- The erm(B) gene was identified as the primary mechanism of resistance in resistant isolates, while erm(TR) and mef(A) were associated with susceptibility.
Conclusions:
- Josamycin demonstrated significant in vitro activity against the majority of S. pyogenes isolates.
- The findings support the use of josamycin as a viable alternative therapeutic option for pharyngitis caused by S. pyogenes.
- Understanding resistance mechanisms is crucial for guiding antibiotic selection.
More Related Videos
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
07:46Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Published on: June 5, 2012
Related Concept Videos
Antimicrobial Effectiveness
Staphylococcal Skin Infections
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis